 |
|
|
| |
SAFETY AND EFFICACY OF SHORT-DURATION TREATMENT WITH GS-9857 COMBINED WITH SOFOSBUVIR/GS-5816 IN TREATMENT-NAĻVE AND DAA-EXPERIENCED GENOTYPE 1 PATIENTS WITH AND WITHOUT CIRRHOSIS
|
| |
| |
Reported by Jules Levin
EASL 2015 April 22-26 Vienna, Austria
Edward J. Gane* 1, Robert H. Hyland2, Yin Ying2, Evguenia Svarovskaia2, Luisa M. Stamm2, Diana M. Brainard2, G. M. Subramanian2, John G. McHutchison2, Christian Schwabe1
1Auckland Clinical Studies, Auckland, New Zealand, 2Gilead Sciences, Foster City , United States
|
| |
|
|
|
|
|
